BridgeBio is significantly boosted this course of an new treatment for cardiac amyloidosis, leveraging the compound. Preliminary trial data suggests promising benefits for those diagnosed with this serious illness. The emphasis represents researchers’ focus to treating unmet patient needs in this heart field. Attruby: BridgeBio's Novel … Read More